[1][2] IMC is headquartered in Ottawa, Ontario, and its board of directors is chaired by Pfizer Canada President Cole Pinnow.

Horner, John Wyeth & Bros., Toronto Pharmacal, Parke, Davis & Co., Seely Manufacturing, Charles E. Frosst & Co., National Drug & Chemical Co., Lyman Bros. & Co., and Henry K. Wampole & Co.

[8] In 2020, IMC contested price regulation reforms introduced by Government of Canada that would require increased financial reporting from pharmaceutical companies, while simultaneously reducing reporting requirements related to veterinary medicines, over-the-counter drugs and most generic medicines.

[9][10] Cole Pinnow, President of Pfizer Canada, was announced as the new chair of IMC's Board of Directors in November 2021.

[3] In April 2022, IMC implemented a revised Code of Ethical Practices that included significant changes aimed to reduce the promotional nature of its educational programs.